Concepedia

Indu Bharathan

IB

5

Publications

183

Citations

5

H-Index

2011

Active since

Affiliations

Quantitative BioSciences(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Indu Bharathan is an author at Quantitative BioSciences specializing in drug discovery, drug development, and medicine.

Top concepts

Publications per year

2011–2024

5

Publications

5

Sulfonyl Fluoride Inhibitors of Fatty Acid Amide Hydrolase

Shakiru O. Alapafuja, Spyros P. Nikas, Indu Bharathan et al. · Journal of Medicinal Chemistry · 2012 · 55 citations · Full text

, , +12

Discovery of a Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905)

Matthew O. Duffey, Tricia J. Vos, Ruth Adams et al. · Journal of Medicinal Chemistry · 2011 · 54 citations · Full text

, , +18

Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRAS<sup>G12C</sup> Inhibitor

Xiaoshen Ma, David L. Sloman, Ruchia Duggal et al. · Journal of Medicinal Chemistry · 2024 · 31 citations

Carbamate and <i>N</i>-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors

Derun Li, Yongqi Deng, Abdelghani Achab et al. · ACS Medicinal Chemistry Letters · 2021 · 25 citations · Full text

Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing

Derun Li, David L. Sloman, Abdelghani Achab et al. · Journal of Medicinal Chemistry · 2022 · 18 citations · Full text

, , +18

Rows per page

1–5 of 5